Refine by
Immune Response Technology Serving Belarus
27 companies found
Technologybased inVancouver, BRITISH COLUMBIA (CANADA)
Ondine Biomedical Inc. is a Canadian life sciences company that has become a global leader in photodisinfection-based therapies to prevent and treat a broad spectrum of infections, including those caused by drug-resistant pathogens. This patented ...
While most research efforts towards treating and preventing COVID-19 have centered on vaccine development and therapies for hospitalized patients, Ondine is seeking to offer a therapeutic approach to those patients who test positive but are not yet ...
Technologybased inHeidelberg, GERMANY
Hummingbird is harnessing the predictive power of blood-borne miRNAs to provide insights into human health and disease. Analysis of miRNAs with Hummingbird’s platform holds the potential for early disease detection, disease-specific prognostics, ...
MiRNAs are small, highly conserved, non-coding RNAs playing crucial roles in the regulation of virtually all aspects of living ...
Technologybased inDallas, TEXAS (USA)
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology ...
Our Vaxxine Platform is designed to harness the immune system to convert the body into its own natural “drug factory” stimulating the production of antibodies. Our technology uses synthetic peptides to mimic and ...
Technologybased inCarlton South, AUSTRALIA
Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular therapies have the promise to cure cancer not just delay disease ...
T cells are part of our adaptive immune system – the system that tailors the body’s response to specific pathogens. Rather than generically attack any antigens, T cells circulate until they encounter a ...
Technologybased inDijon, FRANCE
Oncodesign is a biopharmaceutical company that offers you powerful technologies and tools to guide you through the development of your drug, from medicinal chemistry to drug candidate. Our therapeutic areas are expanding. In addition to oncology, ...
Oncodesign’s Pharmimage® technology module is a pharmaco-imaging module designed to monitor the effect of treatments and to define effective translational biomarkers in precision medicine. It includes translational, optical ...
Technologybased inOxford, UNITED KINGDOM
Vaccitech is a clinical stage T cell immunotherapy and vaccine company developing products to treat and prevent infectious disease and cancer. The company’s proprietary heterologous prime-boost platform comprises Chimpanzee Adenovirus Oxford ...
The patented Vaccitech adenovirus vectors are known as chimpanzee adenovirus Oxford 1 and 2 (ChAdOx1 and ChAdOx2), and are in the group E simian adenovirus family, similar to the widely-studied chimpanzee adenovirus 63. These viruses have been ...
Technologybased inWichita, KANSAS (USA)
Neotherma Oncology is led by experienced healthcare executives who are working toward the dream of more effective treatments for cancer. NeoTherma Oncology is developing a groundbreaking type of radio frequency (RF) thermal treatment for deep solid ...
The energy emitted by VectRx™ increases blood perfusion in the tumor micro-environment, enhancing drug delivery, reversing treatment-resistant hypoxia, and promoting a therapeutic immune ...
Technologybased inSeoul, SOUTH KOREA
GI Innovation is a bio-venture company that researches and develops innovative protein new drugs through well-structured translational research. The primary research and development for GI Innovation is immuno-oncology drug and allergy disease and ...
Controls the immuno-suppressive function of regulatory T cells (Tregs) in tumor microenvironment (TME). Restores T cell function and anti-cancer immune responses in TME. Secures its safety in GLP toxicity ...
Technologybased inRedmond, UTAH (USA)
Redmond Agriculture's goal is to nourish the world's future by crafting natural and sustainable products for healthier animals, soil, and people. Since the 1950s, we’ve been helping farmers and ranchers succeed in doing what they love. Our ancient ...
Technologybased inFramingham, MASSACHUSETTS (USA)
Kephera Diagnostics is a startup that aims to address the public health challenges of global infectious diseases with point of care assay technology. We collaborate with a global community of researchers to develop and translate new technologies ...
COVI-QUANT™ is an ELISA test available through Kephera’s CLIA laboratory. Studies show that not all individuals develop a strong immune response after COVID-19 infection or vaccination, especially those ...
Technologybased inVienna, AUSTRIA
Hookipa Pharma Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on a proprietary arenavirus platform that is designed to reprogram the body’s immune system. We are using our non-replicating and ...
The immune system is the body’s natural defense mechanism against pathogens. Our proprietary technology is capable of targeting and treating disease with a tailored immune response. Our ...
Technologybased inAmes, ALABAMA (USA)
Mazen Animal Health harnesses the power of plant biotechnology to create orally delivered biologics, aimed at significantly improving animal health and welfare. The company's innovative cross-species platform is versatile enough to target various ...
The Oralogics™ Technology Platform from Mazen Animal Health revolutionizes animal vaccination through molecular farming, enabling vaccines to be administered via feed instead of traditional injections. This pioneering approach enhances animal ...
Technologybased inSeattle, WASHINGTON (USA)
AVM Biotechnology is developing and advancing AVM0703, a proprietary formulation of concentrated dexamethasone. This formulation permits the very high dosing necessary to activate the release and trigger the production of the body’s supercharged ...
Most people who get ARDS are already at the hospital for trauma or illness. Lung injuries can occur from trauma, an overwhelming immune response due to an infection, allergic reaction or a cell/gene therapy product ...
Technologybased inTaipei, City, TAIWAN
Bened Biomedical Co., Ltd. was founded in 2015 in Taipei, Taiwan. One of its founders, Professor Ying-Chieh Tsai (National Yang-Ming University), has spent decades studying fermentation and probiotics. It was in his lab where Bened’s first ...
Technologybased inChino, CALIFORNIA (USA)
Our mission at Specialty Enzymes & Probiotics is to improve the well-being of families across the globe, helping you bring people and their pets natural, efficacious ingredients to promote systemic, gut and immune health. We are enzyme pioneers in ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Myeloid Therapeutics is a leader in the development of mRNA-based immunotherapies, focusing on harnessing and enhancing the natural capabilities of myeloid cells to combat cancer. The company's cutting-edge in vivo engineering platform is designed ...
Emerging from the Company’s proprietary ATAK™ CAR receptor library, Myeloid’s novel in vivo engineering platform specifically targets and activates myeloid cells to elicit broader anti-tumor adaptive immunity. Through this ...
Technologybased inBasel, SWITZERLAND
T3 Pharmaceuticals was founded in May 2015 by Simon Ittig, Christoph Kasper, Marlise Amstutz and Helmut Kessmann as a spin-off of the University of Basel. The team has developed an efficient protein delivery technology that is based on the use of ...
T3 Pharma has developed a proprietary cancer therapy platform based on regulating and harnessing the natural behaviours of live bacteria. The genetically engineered bacteria selectively target solid tumors, where they deliver chosen protein payloads ...
Technologybased inBergen, NORWAY
Benchmark Genetics is a leader in aquaculture genetics, present in every major aquaculture market and for a wide range of species. Our five in-house breeding programmes are focusing on three main species: salmon, shrimp and tilapia. We are the ...
Technologybased inHørsholm, DENMARK
We are an AI-immunology platform company decoding the human immune system to discover and develop novel immunotherapies for cancer and infectious diseases. We have developed our AI-immunology core technology to deeply understand the biological ...
EDEN is our second AI platform that rapidly identifies novel, highly protective antigens for the use in pathogen-specific prophylactic vaccines against bacteria. EDEN has been designed to rapidly identify those antigens that will trigger a robust ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
Immunotherapeutic cancer vaccines have generated a lot of interest from oncologists since it was discovered that immune activation can lead to a specific antitumor response.1 However, despite initial progress, most ...